Abstract 4539: NMS-P862, a novel orally available selective small molecule Cdc7 inhibitor with antitumor efficacy in breast cancer
Alessia Montagnoli(Nerviano Medical Sciences), Arturo Galvani(Nerviano Medical Sciences), Sonia Rainoldi(Nerviano Medical Sciences), Dario Ballinari(Nerviano Medical Sciences), Maria Menichincheri(Nerviano Medical Sciences), Rosita Lupi(Nerviano Medical Sciences), Nadia Amboldi(University of Pavia), Eduard Felder, Daniele Pezzetta(Nerviano Medical Sciences), Enrico Pesenti, Francesco Fiorentini(Nerviano Medical Sciences), Marina Ciomei(Nerviano Medical Sciences), Antonella Isacchi(Nerviano Medical Sciences)
Cited by 0
Related Papers
Discovery of drug mode of action and drug repositioning from transcriptional responses
|Proceedings of the National Academy of Sciences|2010|853
Entrectinib, a Pan–TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications
|Molecular Cancer Therapeutics|2016|317
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis.
|Proceedings of the National Academy of Sciences|1995|205